In conclusion, these studies have demonstrated the important role of SIRT3 in cardiovascular disease and may be a new target for the treatment of cardiovascular disease, but the specific mechanism by which SIRT3 ameliorates myocardial tissue injury in DCM patients remains to be refined. Here, SIRT3 is linked to familial dilated cardiomyopathy.